Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purine biosynthesis pathway is a metabolic process that generates purine nucleotides, such as adenosine monophosphate (AMP) and guanosine monophosphate (GMP), from simpler precursors like phosphoribosyl pyrophosphate (PRPP) and amino acids. This pathway is crucial for nucleic acid synthesis and cell proliferation, and its dysregulation can contribute to various diseases, including cancer and gout. Enzymes within this pathway can be targeted therapeutically to modulate purine metabolism in disease states.
Inhibiting key enzymes in the pathway, such as phosphoribosylpyrophosphate amidotransferase (PPAT), to prevent nucleotide synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine biosynthesis pathway.